- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: November 2015
- Public Summary Document (PSD) November 2015 PBAC Meeting - PDF
- Public Summary Document (PSD) November 2015 PBAC Meeting - Word
Ustekinumab – November 2015
Ustekinumab: 45 mg/0.5 mL injection, 1 x 0.5 mL vial, Stelara®
Last updated
4 March 2016